8225 Stock Overview
China Health Group Inc., an investment holding company, provides clinical research services to pharmaceutical and biotechnology companies in the People’s Republic of China.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
China Health Group Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.12 |
| 52 Week High | HK$0.22 |
| 52 Week Low | HK$0.09 |
| Beta | -2.31 |
| 1 Month Change | -11.11% |
| 3 Month Change | -27.27% |
| 1 Year Change | -46.67% |
| 3 Year Change | -74.47% |
| 5 Year Change | -33.33% |
| Change since IPO | -70.73% |
Recent News & Updates
Recent updates
Does China Health Group (HKG:8225) Deserve A Spot On Your Watchlist?
Jan 28
Should You Be Adding China Health Group (HKG:8225) To Your Watchlist Today?
Apr 14Announcing: China Health Group (HKG:8225) Stock Increased An Energizing 170% In The Last Five Years
Mar 09Is China Health Group Inc.'s (HKG:8225) Latest Stock Performance A Reflection Of Its Financial Health?
Feb 10
Does China Health Group (HKG:8225) Deserve A Spot On Your Watchlist?
Jan 14If You Had Bought China Health Group (HKG:8225) Stock A Year Ago, You Could Pocket A 546% Gain Today
Nov 26Shareholder Returns
| 8225 | HK Life Sciences | HK Market | |
|---|---|---|---|
| 7D | 10.1% | -0.7% | 3.5% |
| 1Y | -46.7% | -67.9% | -9.9% |
Return vs Industry: 8225 exceeded the Hong Kong Life Sciences industry which returned -67.1% over the past year.
Return vs Market: 8225 underperformed the Hong Kong Market which returned -10.1% over the past year.
Price Volatility
| 8225 volatility | |
|---|---|
| 8225 Average Weekly Movement | 8.7% |
| Life Sciences Industry Average Movement | 11.5% |
| Market Average Movement | 7.4% |
| 10% most volatile stocks in HK Market | 14.7% |
| 10% least volatile stocks in HK Market | 3.6% |
Stable Share Price: 8225's share price has been volatile over the past 3 months.
Volatility Over Time: 8225's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 42 | n/a | www.chgi.net |
China Health Group Inc., an investment holding company, provides clinical research services to pharmaceutical and biotechnology companies in the People’s Republic of China. The company offers contracted clinical research services; contracted pharmaceutical development services; post launch market research, medical, and medical market services; and other medical services. It also provides hospital management, medical tourism, and specialized hospital services, as well as Venturepharma cloud; and sells drug technologies.
China Health Group Inc. Fundamentals Summary
| 8225 fundamental statistics | |
|---|---|
| Market cap | HK$119.44m |
| Earnings (TTM) | -HK$62.68m |
| Revenue (TTM) | HK$23.15m |
5.2x
P/S Ratio-1.9x
P/E RatioIs 8225 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 8225 income statement (TTM) | |
|---|---|
| Revenue | CN¥21.43m |
| Cost of Revenue | CN¥13.21m |
| Gross Profit | CN¥8.21m |
| Other Expenses | CN¥66.23m |
| Earnings | -CN¥58.01m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.058 |
| Gross Margin | 38.33% |
| Net Profit Margin | -270.78% |
| Debt/Equity Ratio | 0% |
How did 8225 perform over the long term?
See historical performance and comparison